C

Clearside Biomedical
D

CLSD

0.99000
USD
-0.03
(-2.94%)
مغلق
حجم التداول
1,121
الربح لكل سهم
-1
العائد الربحي
-
P/E
-2
حجم السوق
75,085,069
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    ACRS
    -0.08000
    (-3.45%)
    2.24000 USD
    A
    AGEN
    -0.11500
    (-3.34%)
    3.33000 USD
    A
    AUPH
    0.09500
    (1.21%)
    7.92000 USD
    B
    BCRX
    -0.17000
    (-1.81%)
    9.20000 USD
    K
    KALA
    -0.16000
    (-2.33%)
    6.71000 USD
    O
    OCUL
    -0.26000
    (-3.58%)
    6.99500 USD
    S
    SNGX
    -0.02400
    (-0.98%)
    2.42600 USD
    V
    VTGN
    0.09000
    (3.17%)
    2.93000 USD
    المزيد
الأخبار
المقالات

العنوان: Clearside Biomedical

القطاع: Healthcare
الصناعة: Biotechnology
Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye through the suprachoroidal space, or SCS. The company's novel SCS injection platform, utilizing proprietary SCS Microinjector, enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a wide variety of therapies to the macula, retina or choroid to potentially preserve and improve vision in patients with sight-threatening eye diseases.